Picard Medical, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Picard Medical, Inc. (PMI) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.38 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-19
- Picard Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $1.38M, a 654.10% increase year-over-year.
- Picard Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $165.00K, a 17.02% increase year-over-year.
- Picard Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $204.00K, a 53.10% decline year-over-year.
- Picard Medical, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $183.00K, a 5.67% decline year-over-year.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.38M 10-Q · filed 2026-08-19 | $1.54M derived: sum of 2 quarters · filed 2026-08-19 | ||
| 2026-03-31 | $165.00K 10-Q · filed 2026-08-19 | |||
| 2025-12-31 | $754.00K S-1/A · filed 2026-05-01 | |||
| 2025-09-30 | $204.00K 10-Q · filed 2025-11-14 | $387.00K derived: sum of 2 quarters · filed 2026-08-19 | $528.00K derived: sum of 3 quarters · filed 2026-08-19 | |
| 2025-06-30 | $183.00K 10-Q · filed 2026-08-19 | $324.00K derived: sum of 2 quarters · filed 2026-08-19 | ||
| 2025-03-31 | $141.00K 10-Q · filed 2026-08-19 | |||
| 2024-12-31 | $886.00K S-1/A · filed 2026-05-01 | |||
| 2024-09-30 | $435.00K 10-Q · filed 2025-11-14 | $629.00K derived: sum of 2 quarters · filed 2025-11-14 | $660.00K derived: sum of 3 quarters · filed 2025-11-14 | |
| 2024-06-30 | $194.00K 10-Q · filed 2025-11-14 | $225.00K derived: sum of 2 quarters · filed 2025-11-14 | ||
| 2024-03-31 | $31.00K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |